Literature DB >> 8996430

Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.

E Cambau1, E Perani, I Guillemin, P Jamet, B Ji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 8996430     DOI： 10.1016/S0140-6736(05)60888-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  30 in total

1.  Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.

Authors:  Jean-Noël Dauendorffer; Isabelle Guillemin; Alexandra Aubry; Chantal Truffot-Pernot; Wladimir Sougakoff; Vincent Jarlier; Emmanuelle Cambau
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Molecular drug susceptibility testing and genotyping of Mycobacterium leprae strains from South America.

Authors:  Pushpendra Singh; Philippe Busso; Alberto Paniz-Mondolfi; Nacarid Aranzazu; Marc Monot; Nadine Honore; Andrea de Faria Fernandes Belone; Marcos Virmond; Maria Esther Villarreal-Olaya; Carlos Rivas; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

3.  High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.

Authors:  B Ji; P Jamet; S Sow; E G Perani; I Traore; J H Grosset
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India.

Authors:  Niranjan Prakash Mahajan; Mallika Lavania; Itu Singh; Saraswati Nashi; Veeramani Preethish-Kumar; Seena Vengalil; Kiran Polavarapu; Chevula Pradeep-Chandra-Reddy; Muddasu Keerthipriya; Anita Mahadevan; Tagaduru Chickabasaviah Yasha; Bevinahalli Nanjegowda Nandeesh; Krishnamurthy Gnanakumar; Gareth J Parry; Utpal Sengupta; Atchayaram Nalini
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

5.  Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae.

Authors:  Kazumasa Yokoyama; Hyun Kim; Tetsu Mukai; Masanori Matsuoka; Chie Nakajima; Yasuhiko Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

Review 6.  Mycobacterium leprae: genes, pseudogenes and genetic diversity.

Authors:  Pushpendra Singh; Stewart T Cole
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

7.  Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.

Authors:  Stéphanie Matrat; Stéphanie Petrella; Emmanuelle Cambau; Wladimir Sougakoff; Vincent Jarlier; Alexandra Aubry
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

8.  Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients.

Authors:  Adalgiza da Silva Rocha; Maria das Graças Cunha; Lucia Martins Diniz; Claudio Salgado; Maria Araci P Aires; José Augusto Nery; Eugênia Novisck Gallo; Alice Miranda; Monica M F Magnanini; Masanori Matsuoka; Euzenir Nunes Sarno; Philip Noel Suffys; Maria Leide W de Oliveira
Journal:  J Clin Microbiol       Date:  2012-04-11       Impact factor: 5.948

9.  Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?

Authors:  Stéphanie Matrat; Emmanuelle Cambau; Vincent Jarlier; Alexandra Aubry
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

10.  Case Report: Multidrug-Resistant Mycobacterium leprae in a Case of Smear-Negative Relapse.

Authors:  Divya Kamat; Tarun Narang; Madhvi Ahuja; Mallika Lavania; Sunil Dogra
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.